|

Ocrelizumab (US) Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Ocrevus

Pipeline

Phase 3: 1

Top Sponsors

  • Northwestern University1
  • Amgen1

Indications

  • Multiple Sclerosis2
  • Relapsing-remitting Multiple Sclerosis (RRMS)1
  • Weight Loss1

Mobile, Alabama1 trial

Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

University of South Alabama

Phase 3

Chicago, Illinois1 trial

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Northwestern Memorial Hospital

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.